Audeara Ltd. (AUA) AI Stock Analysis

• Market Cap: AU$4.14M
• Dividend Yield: N/A
• Average Volume (3M): 101.41K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.32
• Revenue Growth: 79.82%
• EPS Growth: 27.00%
• Country: AU
• Employees: N/A
• Sector: Technology
• Sector Strength: 86
• Industry: Consumer Electronics
• EPS (TTM): -0.01
• Shares Outstanding: 179,934,390
• 10 Day Avg. Volume: 207,808
• 30 Day Avg. Volume: 101,412
• PEG Ratio: -0.06
• Price to Book (P/B): -27.94
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -11.92
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 37 Underperform
• Price Target: AU$0.00 ▼(-100.00%Downside)

Audeara Ltd. exhibits significant financial and technical weaknesses. The company's negative profitability, cash flow challenges, and reliance on liabilities are major concerns, compounded by bearish technical indicators. The stock's negative P/E ratio further underscores valuation issues, making it an unattractive investment at this time.

Audeara Ltd. Business Overview & Revenue Model

Company Description

Audeara Limited, a hearing health technology company, engages in the development and sale of personalized listening products in Australia and North America. It provides A–01 and A-02 Bluetooth headphones; A-02 TV bundles; and BT–01 wireless transceivers. The company was incorporated in 2015 and is based in Fortitude Valley, Australia.

How the Company Makes Money

Audeara Ltd. generates revenue primarily through the sale of its tailored audio products, including headphones and related accessories. The company's headphones are unique in that they incorporate personalized hearing tests to adjust sound output according to the user's specific hearing needs, providing a customized listening experience. This product differentiation allows Audeara to target both the consumer electronics market and the hearing health industry. Revenue streams include direct sales through the company's website and third-party retail partners. Additionally, Audeara benefits from partnerships with healthcare providers and audiologists who recommend their products to patients, further driving sales. The company's earnings are significantly influenced by its ability to innovate and maintain strong partnerships within both the consumer electronics and healthcare sectors.

Audeara Ltd. Financial Statement Overview

Summary

Audeara Ltd. faces considerable financial challenges despite some revenue growth. The company struggles with profitability and cash generation, as evidenced by negative net income and free cash flow. The balance sheet shows declining equity and high reliance on liabilities, pointing to potential financial instability.

Income Statement

Audeara Ltd. has demonstrated some growth with total revenue increasing from 2023 to 2024. However, the company has consistently reported negative EBIT and net income, indicating ongoing operational challenges. The gross profit margin has also declined slightly, suggesting pressure on cost management or pricing strategies.

Balance Sheet

The company's debt-to-equity ratio remains low, which is positive, and indicates relatively low leverage. However, the significant decrease in stockholders' equity over time and the negative equity in earlier years highlight financial instability and risk. The equity ratio has deteriorated, reflecting a reliance on liabilities to finance assets.

Cash Flow

While free cash flow has improved compared to previous years, it remains negative, indicating challenges in generating cash from operations. Operating cash flow is consistently negative, and the free cash flow to net income ratio suggests inefficiency in converting income into cash.

Breakdown	TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	4.20M	3.19M	2.75M	2.07M	1.12M	902.76K
Gross Profit	963.32K	943.12K	989.76K	946.11K	510.33K	-260.02K
EBITDA	-3.12M	-2.75M	-3.59M	-2.82M	-1.08M	-62.21K
Net Income	-1.98M	-1.60M	-3.74M	-2.95M	-1.25M	-454.00K
Balance Sheet
Total Assets	3.43M	4.89M	4.73M	5.49M	6.57M	561.16K
Cash, Cash Equivalents and Short-Term Investments	1.71M	1.27M	2.62M	2.87M	5.74M	―
Total Debt	483.28K	112.18K	210.74K	275.11K	67.60K	1.33M
Total Liabilities	1.97M	3.28M	1.57M	1.41M	665.76K	1.65M
Stockholders Equity	1.46M	1.61M	3.17M	4.08M	5.91M	-1.09M
Cash Flow
Free Cash Flow	-1.36M	-1.34M	-2.98M	-3.78M	-1.11M	-82.78K
Operating Cash Flow	-1.35M	-1.33M	-2.97M	-3.58M	-1.08M	-65.53K
Investing Cash Flow	-8.47K	-8.47K	-16.00K	-229.26K	-23.71K	-17.25K
Financing Cash Flow	1.34M	-10.88K	2.74M	939.73K	7.10M	-35.12K

Audeara Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.02
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:AUA, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.03, and below the 200-day MA of 0.04, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 12.10 is Positive, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:AUA.

Audeara Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	63 Neutral	$33.22B	5.99	-11.76%	1.91%	5.54%	-19.87%
AUA	37 Underperform	AU$4.14M	―	-107.59%	―	79.82%	27.00%
CHEOF		$12.63B	51.72	20.61%	1.40%	―	―
NNCSF		$819.99M	65.28	9.23%	―	―	―
SOMNF		$92.56M	―	-15.86%	―	―	―
RHT	62 Neutral	AU$17.93M	140.00	-3.11%	―	89.13%	69.57%
PXS		€324.67M	24.21	6.68%	―	―	―

Audeara Ltd. Corporate Events

Audeara Director Increases Shareholding

Audeara Limited has announced a change in the director’s interest, specifically involving David Trimboli, who has acquired additional ordinary fully paid shares through an on-market trade. This acquisition reflects a minor adjustment in the director’s holdings, which could indicate confidence in the company’s future performance. The impact on stakeholders appears minimal, as the transaction involves a relatively small number of shares and does not significantly alter the overall shareholding structure.

Audeara Limited Achieves Record Revenue in FY25

Audeara Limited has reported record revenue for the first 11 months of FY25, with a 14% increase compared to FY24 and a 25% increase compared to FY23. This growth is attributed to the successful launch of the Clinico Sound Earbuds CS1 in Taiwan, strategic international partnerships, and increased Australian wholesale revenue. The company anticipates further growth in June 2025 and into FY26 through continued collaborations and product launches.

Audeara Director Increases Stake with New Share Acquisition

Audeara Ltd. has announced a change in the director’s interest, with David Trimboli acquiring an additional 105,000 ordinary fully paid shares through an on-market trade. This acquisition reflects a modest increase in Trimboli’s stake in the company, potentially signaling confidence in Audeara’s strategic direction and future growth prospects.

Audeara Ltd. Announces Change in Substantial Holding

Audeara Ltd. has announced a change in substantial holding, indicating that a holder has ceased to be a substantial holder in the company. This change involves alterations in relevant interests and associations related to voting securities, which may impact the company’s shareholder structure and influence its governance dynamics.

Audeara Director’s Shareholding Update

Audeara Limited has announced a change in the director’s interest, specifically involving David Trimboli. The update reveals that Trimboli has acquired 14,174 ordinary fully paid shares through an on-market trade, bringing his total to 2,451,955 shares. This change in shareholding reflects a minor adjustment in the company’s internal ownership structure, which may impact stakeholder perceptions regarding governance and investment strategies.

Audeara Director Increases Stake Through Share Acquisition

Audeara Limited has announced a change in the director’s interest notice concerning James Fielding, a director and shareholder. The notice details the acquisition of additional ordinary fully paid shares by James Fielding Family Pty Ltd, increasing the total number of shares held. This transaction, conducted through on-market trades, reflects a strategic move by the director to enhance his stake in the company, potentially signaling confidence in Audeara’s future prospects.

Audeara Director Increases Stake in Company

Audeara Limited announced a change in the director’s interest, with James Fielding acquiring an additional 39,345 ordinary fully paid shares through an on-market trade. This acquisition reflects a slight increase in Fielding’s stake in the company, potentially signaling confidence in Audeara’s future prospects and stability within its market position.

Audeara Ltd Reports Strong Q3 FY25 Performance and Strategic Growth

Audeara Ltd reported strong financial and operational performance for Q3 FY25, highlighted by the launch of Clinico-branded earbuds in Taiwan and a significant purchase order from Avedis Zildjian. The company also secured a reseller agreement with George & Matilda Eyecare, expanding its sales channels. Financially, Audeara achieved record cash receipts and a substantial increase in quarterly revenues, indicating effective cost management and strategic growth initiatives. Looking forward, the company is poised to capitalize on its momentum with further product launches and international market expansion.